Director Wendy Yarno to retire from Iovance board at 2026 annual meeting

IOVANCE BIOTHERAPEUTICS, INC.

Wendy Yarno will retire and not stand for re-election at the June 2026 annual meeting.
Yarno will serve out her current director term until the annual meeting.
Retirement is not due to any disagreement with the company on operations, policies, or practices.
No replacement director has been announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.